Loading...

ANI Pharmaceuticals, Inc.

ANIPNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$67.48
$0.71(1.06%)

ANI Pharmaceuticals, Inc. (ANIP) Company Profile & Overview

Explore ANI Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

ANI Pharmaceuticals, Inc. (ANIP) Company Profile & Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEONikhil Lalwani

Contact Information

218 634 3500
210 Main Street West, Baudette, MN, 56623

Company Facts

897 Employees
IPO DateMay 5, 2000
CountryUS
Actively Trading

Frequently Asked Questions

;